Early eicosapentaenoic acid treatment after percutaneous coronary intervention reduces acute inflammatory responses and ventricular arrhythmias in patients with acute myocardial infarction: A randomized, controlled study

International Journal of Cardiology

Volumn 176, Issue 3, 2014, Pages 577-582

  Doi, Masayuki ^a   Nosaka, Kazumasa ^a   Miyoshi, Toru ^b   Iwamoto, Mutsumi ^a   Kajiya, Masahito ^a   Okawa, Keisuke ^a   Nakayama, Rie ^a   Takagi, Wataru ^a   Takeda, Ko ^a   Hirohata, Satoshi ^c   Ito, Hiroshi ^b  

^a KAGAWA PREFECTURAL CENTRAL HOSPITAL   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c International Center   (Japan)

Author keywords

Acute myocardial infarction; Arrhythmia; Complication; Eicosapentaenoic acid

Indexed keywords

C REACTIVE PROTEIN; ICOSAPENTAENOIC ACID;

AGED; ANTERIOR WALL MYOCARDIAL INFARCTION; ARRHYTHMIAS, CARDIAC; BIOASSAY; CONTROLLED STUDY; FEMALE; HUMAN; INFLAMMATION; MALE; METABOLISM; MULTIMODALITY CANCER THERAPY; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

AGED; ANTERIOR WALL MYOCARDIAL INFARCTION; ARRHYTHMIAS, CARDIAC; C-REACTIVE PROTEIN; COMBINED MODALITY THERAPY; EICOSAPENTAENOIC ACID; ENDPOINT DETERMINATION; FEMALE; HUMANS; INFLAMMATION; MALE; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84908179513     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.08.055     Document Type: Article

References (37)

1. N.G. Frangogiannis, C.W. Smith, and M.L. Entman The inflammatory response in myocardial infarction Cardiovasc Res 53 2002 31 47
2. M. Suleiman, R. Khatib, and Y. Agmon Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction predictive role of C-reactive protein J Am Coll Cardiol 47 2006 962 968
3. M. Suleiman, D. Aronson, and S.A. Reisner Admission C-reactive protein levels and 30-day mortality in patients with acute myocardial infarction Am J Med 115 2003 695 701
4. K.O. Pietila, A.P. Harmoinen, J. Jokiniitty, and A.I. Pasternack Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment Eur Heart J 17 1996 1345 1349
5. M. Nian, P. Lee, N. Khaper, and P. Liu Inflammatory cytokines and postmyocardial infarction remodeling Circ Res 94 2004 1543 1553
6. F. Bursi, S.A. Weston, J.M. Killian, S.E. Gabriel, S.J. Jacobsen, and V.L. Roger C-reactive protein and heart failure after myocardial infarction in the community Am J Med 120 2007 616 622
7. A.M. Arruda-Olson, M. Enriquez-Sarano, and F. Bursi Left ventricular function and C-reactive protein levels in acute myocardial infarction Am J Cardiol 105 2010 917 921
8. I. Vedin, T. Cederholm, and Y. Freund-Levi Reduced prostaglandin F2 alpha release from blood mononuclear leukocytes after oral supplementation of omega3 fatty acids: the OmegAD study J Lipid Res 51 2010 1179 1185
9. R.I. Sperling, A.I. Benincaso, C.T. Knoell, J.K. Larkin, K.F. Austen, and D.R. Robinson Dietary omega-3 polyunsaturated fatty acids inhibit phosphoinositide formation and chemotaxis in neutrophils J Clin Invest 91 1993 651 660
10. C.N. Serhan, C.B. Clish, J. Brannon, S.P. Colgan, N. Chiang, and K. Gronert Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing J Exp Med 192 2000 1197 1204
11. C.N. Serhan Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not? Am J Pathol 177 2010 1576 1591
12. G.L. Bannenberg, N. Chiang, and A. Ariel Molecular circuits of resolution: formation and actions of resolvins and protectins J Immunol 174 2005 4345 4355
13. C. Arnold, M. Markovic, and K. Blossey Arachidonic acid-metabolizing cytochrome P450 enzymes are targets of {omega}-3 fatty acids J Biol Chem 285 2010 32720 32733
14. R. Marchioli, F. Barzi, and E. Bomba Early protection against sudden death by n- 3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione Circulation 105 2002 1897 1903
15. A. Macchia, G. Levantesi, and M.G. Franzosi Left ventricular systolic dysfunction, total mortality, and sudden death in patients with myocardial infarction treated with n - 3 polyunsaturated fatty acids Eur J Heart Fail 7 2005 904 909
16. K. Thygesen, J.S. Alpert, and H.D. White Universal definition of myocardial infarction Circulation 116 2007 2634 2653
17. I. Kushner, M.L. Broder, and D. Karp Control of the acute phase response. Serum C-reactive protein kinetics after acute myocardial infarction J Clin Invest 61 1978 235 242
18. K. Pietila, W.T. Hermens, and A. Harmoinen Comparison of peak serum C-reactive protein and hydroxybutyrate dehydrogenase levels in patients with acute myocardial infarction treated with alteplase and streptokinase Am J Cardiol 80 1997 1075 1077
19. A. Leaf, J.X. Kang, Y.F. Xiao, and G.E. Billman Clinical prevention of sudden cardiac death by n - 3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n - 3 fish oils Circulation 107 2003 2646 2652
20. K.H. Newby, T. Thompson, A. Stebbins, E.J. Topol, R.M. Califf, and A. Natale Sustained ventricular arrhythmias in patients receiving thrombolytic therapy: incidence and outcomes. The GUSTO Investigators Circulation 98 1998 2567 2573
21. S.M. Al-Khatib, C.B. Granger, and Y. Huang Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors, and outcomes Circulation 106 2002 309 312
22. C.M. Gibson, Y.B. Pride, and J.L. Buros Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction J Am Coll Cardiol 51 2008 546 551
23. R.H. Mehta, K.J. Harjai, and L. Grines Sustained ventricular tachycardia or fibrillation in the cardiac catheterization laboratory among patients receiving primary percutaneous coronary intervention: incidence, predictors, and outcomes J Am Coll Cardiol 43 2004 1765 1772
24. R.H. Mehta, A.Z. Starr, and R.D. Lopes Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention JAMA 301 2009 1779 1789
25. J.P. Piccini, J.A. White, and R.H. Mehta Sustained ventricular tachycardia and ventricular fibrillation complicating non-ST-segment-elevation acute coronary syndromes Circulation 126 2012 41 49
26. Dietary supplementation with n - 3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico Lancet 354 1999 447 455
27. M.L. Burr, A.M. Fehily, and J.F. Gilbert Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART) Lancet 2 1989 757 761
28. D.W. Nilsen, G. Albrektsen, K. Landmark, S. Moen, T. Aarsland, and L. Woie Effects of a high-dose concentrate of n - 3 fatty acids or corn oil introduced early after an acute myocardial infarction on serum triacylglycerol and HDL cholesterol Am J Clin Nutr 74 2001 50 56
29. B. Rauch, R. Schiele, and S. Schneider OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction Circulation 122 2010 2152 2159
30. D. Kromhout, E.J. Giltay, and J.M. Geleijnse n- 3 fatty acids and cardiovascular events after myocardial infarction N Engl J Med 363 2010 2015 2026
31. Y.T. Zhao, Q. Chen, and Y.X. Sun Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary heart disease: a meta-analysis of randomized controlled trials Ann Med 41 2009 301 310
32. K.B. Filion, F. El Khoury, M. Bielinski, I. Schiller, N. Dendukuri, and J.M. Brophy Omega-3 fatty acids in high-risk cardiovascular patients: a meta-analysis of randomized controlled trials BMC Cardiovasc Disord 10 2010 24
33. H. Leon, M.C. Shibata, S. Sivakumaran, M. Dorgan, T. Chatterley, and R.T. Tsuyuki Effect of fish oil on arrhythmias and mortality: systematic review BMJ 337 2008 a2931
34. M. Yokoyama, H. Origasa, and M. Matsuzaki Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis Lancet 369 2007 1090 1098
35. H.M. Den Ruijter, G. Berecki, and A.O. Verkerk Acute administration of fish oil inhibits triggered activity in isolated myocytes from rabbits and patients with heart failure Circulation 117 2008 536 544
36. J.H. Wu, R. Marchioli, and M.G. Silletta Plasma phospholipid omega-3 fatty acids and incidence of postoperative atrial fibrillation in the OPERA trial J Am Heart Assoc 2 2013 e000397
37. T. Madsen, J.H. Christensen, A.M. Thogersen, E.B. Schmidt, and E. Toft Intravenous infusion of n - 3 polyunsaturated fatty acids and inducibility of ventricular tachycardia in patients with implantable cardioverter defibrillator Europace 12 2010 941 946